Monday, August 10, 2026
7:00 - 8:00 AM Breakfast
Welcome and Opening Kern Lecture
8:00 - 9:00AM “Topic: Cardiovascular Disease, Lipids, and Inflammation” - Kathryn Moore, PhD, NYU
Session 1: Peripheral Lipids and Neurodegenerative Disease
9:00-10:45 AM
“Topic: HDL, Peripheral Lipoproteins, and AD Risk” - Cheryl Wellington, PhD, University of British Columbia“Activating Lipoprotein Lipase with ApoC‑II Mimetic Peptides” - Kimberley Bruce, PhD, University Colorado “The ATN Framework for Alzheimer’s Disease Staging: A role for Vascular Risk Factors.” - Ann Cohen, PhD, University of Pittsburgh
10:45 - 11:00 AM Coffee Break
Session 2: Causative Factors in Hyperlipidemia
11:00 - 12:30 PM
“When Fat Cells Miscommunicate: Adipocyte Signaling in Hyperlipidemia” - Philipp Scherer, PhD, University of Texas Southwestern Medical Center“Topic: GIP/GLP-1/and Glucagon Regulation of Lipid Metabolism and Focus on Effects in Adipose” - William Roell, PhD, Eli Lilly and Company
Short Talk(s) Chosen from Abstracts or Award Talk
12:30 - 1:30PM Lunch
1:30 - 4:00 PM Afternoon Break / Optional Structured Activity
Session 3: Advances in Lipoproteins
4:00 – 6:00 PM
“Topic: Brain-derived Lipoproteins” - John Melchior, PhD, Pacific Northwest National Laboratory“Emerging Technologies Provide New Insight into Lipoprotein Metabolism” - Saskia Neher, PhD, University of North Carolina at Chapel Hill
Short Talk(s) Chosen from Abstracts or Award Talk
Lightning Talks
6:00 – 6:30 PM
Poster Session & Reception
6:45 – 8:15 PM
Updated - March 11, 2026